Clinical trial
Policosanol for the Treatment of Hypercholesterolemia
NCT00255216 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00255216 |
|---|---|
| Title | Policosanol for the Treatment of Hypercholesterolemia |
| Official title | Policosanol for the Treatment of Hypercholesterolemia |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hyperlipidemia |
| Intervention type | Drug |
| Interventions | Policosanol supplement (oral capsule) vs. placebo |
| Enrollment | 40 |
| Start date | Jan 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Nov 18, 2005 |
| Last update posted | Mar 30, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: